Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety ReportsAlem Zekarias, Birgitta Grundmark|Drug Safety|2020Cited by 40
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network StudyOskar Gauffin, G. Niklas Norén, Suvi Asikainen et al.|Drug Safety|2023Cited by 19